Abstract
The most abundant proteins on high-density lipoproteins (HDLs), apolipoproteins A-I (APOA1) and A-II (APOA2), are determinants of HDL function with 15 and 9 proteoforms (chemical-structure variants), respectively. The relative abundance of these proteoforms in human serum is associated with HDL cholesterol efflux capacity, and cholesterol content. However, the association between proteoform concentrations and HDL size is unknown. We employed a novel native-gel electrophoresis technique, clear native gel-eluted liquid fraction entrapment electrophoresis (CN-GELFrEE) paired with mass spectrometry of intact proteins to investigate this association. Pooled serum was fractionated using acrylamide gels of lengths 8 and 25 cm. Western blotting determined molecular diameter and intact-mass spectrometry determined proteoform profiles of each fraction. The 8- and 25 cm experiments generated 19 and 36 differently sized HDL fractions, respectively. The proteoform distribution varied across size. Fatty-acylated APOA1 proteoforms were associated with larger HDL sizes (Pearson’s R = 0.94, p = 4 × 10-7) and were approximately four times more abundant in particles larger than 9.6 nm than in total serum; HDL-unbound APOA1 was acylation-free and contained the pro-peptide proAPOA1. APOA2 proteoform abundance was similar across HDL sizes. Our results establish CN-GELFrEE as an effective lipid-particle separation technique and suggest that acylated proteoforms of APOA1 are associated with larger HDL particles.
Original language | English (US) |
---|---|
Pages (from-to) | 1455-1465 |
Number of pages | 11 |
Journal | Journal of Proteome Research |
Volume | 22 |
Issue number | 5 |
DOIs | |
State | Published - May 5 2023 |
Funding
This work is in part an improvement upon Chapter 4 of a dissertation by Henrique dos Santos Seckler entitled: “Apolipoprotein Proteoforms and Their Association with Cardiovascular Metabolism”, reference herein. This work was supported by the following grants: American Heart Association: #SDG 27250022, National Institute of Health: #K23 HL133601-01, and National Institute of General Medical Sciences: #P41 GM108569. The Coronary Artery Risk Development in Young Adults Study (CARDIA) is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with the University of Alabama at Birmingham (HHSN268201800005I and HHSN268201800007I), Northwestern University (HHSN268201800003I), University of Minnesota (HHSN268201800006I), and Kaiser Foundation Research Institute (HHSN268201800004I). This paper has been reviewed by CARDIA for scientific content.
Keywords
- APOA1
- HDL
- apolipoproteins
- cardiovascular disease
- cholesterol/efflux
- proteomics
ASJC Scopus subject areas
- General Chemistry
- Biochemistry